Dobson et al., 2005 - Google Patents
Naı¨ ve Antibody Libraries from Natural RepertoiresDobson et al., 2005
- Document ID
- 9006853149965374028
- Author
- Dobson C
- Minter R
- Hart-Shorrock C
- Publication year
- Publication venue
- Phage Display in Biotechnology and Drug Discovery
External Links
Snippet
Large nonimmune antibody repertoires (> 1011 antibodies) are now used routinely for the isolation of therapeutic antibodies since they contain high affinity antibodies and are very diverse. Indeed, subnanomolar antibodies have been isolated from large nonimmune …
- 241000282414 Homo sapiens 0 abstract description 71
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Edwards et al. | The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS | |
| JP6723392B2 (en) | Multispecific monoclonal antibody | |
| JP6193913B2 (en) | Simultaneously integrated selection and evolution of antibody / protein performance and expression in the production host | |
| Steidl et al. | In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification | |
| CA2119930C (en) | Production of chimeric antibodies - a combinatorial approach | |
| JP6244301B2 (en) | Soluble polypeptide | |
| KR101380570B1 (en) | Human anti-interferon gamma antibodies and methods of use thereof | |
| US9464286B2 (en) | High throughput generation and affinity maturation of humanized antibody | |
| CN103261220A (en) | Methods for the generation of multispecific and multivalent antibodies | |
| US20050214857A1 (en) | Method for displaying loops from immunoglobulin domains in different contexts | |
| O’Brien et al. | Antibody phage display: methods and protocols | |
| JP2019501885A (en) | Multispecific antibody | |
| CN103261222A (en) | Novel antibody derivatives | |
| JPH07502167A (en) | Production of anti-autoantibodies derived from antibody segment repertoires and displayed on phage | |
| Griffiths | Production of human antibodies using bacteriophage | |
| KR102139388B1 (en) | Identifying affinity-matured human antibodies | |
| Groves et al. | Applications of ribosome display to antibody drug discovery | |
| US20230332175A1 (en) | Transgenic rabbit with common light chain | |
| US9090994B2 (en) | Antibody humanization by framework assembly | |
| Cary et al. | Characterization of superantigen-induced clonal deletion with a novel clan III-restricted avian monoclonal antibody: exploiting evolutionary distance to create antibodies specific for a conserved VH region surface | |
| CN107207581B (en) | Method for preparing optimized therapeutic molecules | |
| Son et al. | Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library | |
| EP3394256B1 (en) | A method of generating an antibody naïve library, said library and application(s) thereof | |
| Dobson et al. | Naı¨ ve Antibody Libraries from Natural Repertoires | |
| Burton et al. | Human antibodies to HIV-1 by recombinant DNA methods |